REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,972 | -56.3% | 695 | -3.5% | 0.00% | – |
| Q2 2023 | $18,223 | +86676.2% | 720 | +9.1% | 0.00% | – |
| Q1 2023 | $21 | +2000.0% | 660 | +1000.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 60 | +15.4% | 0.00% | – |
| Q3 2022 | $1,000 | -90.0% | 52 | -93.1% | 0.00% | – |
| Q4 2021 | $10,000 | -88.2% | 750 | -75.4% | 0.00% | -100.0% |
| Q3 2021 | $85,000 | -5.6% | 3,050 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $90,000 | +5.9% | 3,050 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $85,000 | +157.6% | 3,050 | +165.2% | 0.00% | – |
| Q4 2020 | $33,000 | -43.1% | 1,150 | -50.0% | 0.00% | – |
| Q3 2020 | $58,000 | +16.0% | 2,300 | +11.9% | 0.00% | – |
| Q2 2020 | $50,000 | +92.3% | 2,055 | +17.6% | 0.00% | – |
| Q1 2020 | $26,000 | -7.1% | 1,748 | 0.0% | 0.00% | – |
| Q4 2019 | $28,000 | -88.8% | 1,748 | -90.9% | 0.00% | -100.0% |
| Q3 2019 | $251,000 | – | 19,270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |